News from kiadis pharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

13 May, 2015, 07:00 BST EMA Grants Kiadis Pharma's Lead Product ATIR™ ATMP Certificate for Quality and Non-Clinical Data

Kiadis Pharma B.V. ("Kiadis Pharma" or "the Company"), a clinical stage biopharmaceutical company developing innovative immunotherapy treatments,...


07 May, 2015, 07:00 BST Kiadis Pharma Appoints Dr. Vincent Brichard to its Supervisory Board

Kiadis Pharma B.V. ("Kiadis Pharma" or "the Company"), a clinical stage biopharmaceutical company developing innovative immunotherapy treatments,...


09 Dec, 2014, 07:00 GMT Kiadis Pharma Presents Positive Data from a Pre-specified Interim Analysis of the Phase II Clinical Program with its Lead Product ATIR™

~ Data confirms the potential of ATIR™ in partially matched hematopoietic stem cell transplants ~ Kiadis Pharma B.V. ("Kiadis Pharma"), a clinical...


30 Oct, 2014, 07:00 GMT Kiadis Pharma's Lead Product ATIR™ Granted Orphan Drug Designation by EMA for the Treatment of Acute Myeloid Leukemia

Kiadis Pharma B.V. ("Kiadis Pharma" or "the Company"), a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for...


03 Sep, 2014, 07:00 BST Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer

~ Clinical and Business Development expert re-joins the Company ~ Kiadis Pharma B.V. ("Kiadis Pharma", "Kiadis" or "the Company"), a clinical stage...


24 Mar, 2014, 07:00 GMT Kiadis Pharma Organizes a Satellite Symposium on March 30, 2014 at the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing T-cell immunotherapy treatments for blood cancers, today announces that it...


29 Jan, 2014, 07:00 GMT Kiadis Pharma Initiates Collaboration for Personalized Immunotherapies Using ATIR[TM]with Technische Universität München within Munich Biotech Cluster

~ Prof. Dr. Angela Krackhardt from the Klinikum rechts der Isar of the Technische Universität München to lead the project ~ Kiadis Pharma B.V., a...


05 Dec, 2013, 07:00 GMT Kiadis Pharma Participates in Haploidentical Transplantation 2013 Forum

~ Prior to the American Society of Hematology Annual Meeting ~ Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments...


18 Nov, 2013, 07:00 GMT Kiadis Pharma Provides Positive Update on its Phase II Clinical Program with Blood Cancer Treatment ATIR™

~ 6 month follow-up data expected in H1 2014 ~ Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood...


07 Oct, 2013, 07:00 BST Kiadis Pharma Secures Manufacturing Services Agreement for its Phase II Clinical Program with Blood Cancer Treatment ATIR™ with the German Red Cross Blood Donor Service

~ Technology transfer successfully completed and manufacturing underway ~ Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing...


11 Sep, 2013, 07:00 BST Kiadis Pharma Completes Five-year Follow-up of its Phase I/II Clinical Study with Blood Cancer Product ATIR™ and Study Meets Primary Objective

~ 67% survival demonstrated after 5 years and no transplant related mortalities ~ Manfred Ruediger, CEO of Kiadis Pharma, gives more information on...


23 Jul, 2013, 07:00 BST Kiadis Pharma to Receive GMP Manufacturing License and GMP Certificate

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that its Quality Control (QC) ...


26 Jun, 2013, 07:00 BST Kiadis Pharma Awarded a €3 Million Innovation Credit from the Dutch Government for Phase II Clinical Development Program

Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it will receive an...


04 Jan, 2011, 09:18 GMT Kiadis Pharma Signs License Agreement With Hospira to Commercialize ATIR(TM) in Europe and Asia

- Partnership Would Advance Innovative Stem Cell Transplant Product Kiadis Pharma, a biopharmaceutical company based in The Netherlands, announced...